Pancreatic Cancer Research

ResearcherNanjing Medical UniversityActive in the last 2 years

Bin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6708-4101; OpenAlex author ID A5100427364. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. [Retracted] miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. Co-author DOI 10.3892/mmr.2025.13475↗
  2. [Corrigendum] miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression. Co-author DOI 10.3892/mmr.2022.12738↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ying Xin · 2 shared papers, 2022–2025 · strength 0.41
  2. Yunpeng Peng · 2 shared papers, 2022–2025 · strength 0.41
  3. Jishu Wei · 2 shared papers, 2022–2025 · strength 0.41
  4. Yi Miao · 2 shared papers, 2022–2025 · strength 0.41
  5. Xinchun Liu · 2 shared papers, 2022–2025 · strength 0.41
  6. Jingjing Zhang · 1 shared paper, 2025 · strength 0.26
  7. Jingjing Zhang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.